|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
HCC cell lines HepG2, HUH-6, HUH-7, Mahlavu, and the non-HCC control MCF-7, gave clear negative results.
|
2164560 |
1990 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
AlteredExpression |
BEFREE |
The LINC00339 expression in HCC cancer cells (HUH7, HepG2, HUH-6, and SK-Hep-1) and tissues was assessed by quantitative real-time polymerase chain reaction (qRT-PCR).
|
31081143 |
2019 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
In this study, the anticarcinogenic effects of resveratrol against hepatitis B virus (HBV)-induced HCC were investigated by using HBV X-protein-overexpressing Huh7 (Huh7-HBx) human hepatoma cells.
|
28385009 |
2017 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
Huh‑7 HCC cell line was selected for the present study.
|
29693700 |
2018 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
Application of ɑ-Tocotrienol-Loaded Biocompatible Precirol in Attenuation of Doxorubicin Dose-Dependent Behavior in HUH-7 Hepatocarcinoma Cell Line.
|
31390910 |
2020 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
This approach induces >40% drug release from thermally responsive doxorubicin-loaded liposomes within a 3.2 mm radius of the zero point with <10% release in the surrounding area, leading to a >2.5 therapeutic index in Huh 7 hepatocellular carcinoma cells.
|
30286280 |
2018 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
AlteredExpression |
BEFREE |
We analyzed sorafenib effects on apoptosis induction, NAD salvage, mitochondrial function, and related signaling pathways in HCC cell lines (HepG2, Hep3B, und HUH7) overexpressing SIRT1 or supplemented with the NAD metabolite nicotinamide mononucleotide (NMN) compared to controls.
|
31430957 |
2019 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
We compared the overall gene expression profile of poorly-differentiated (HLE, HLF, SNU-449) to well-differentiated (HUH7, HEPG2, HEP3B) HCC cell lines in three publicly available microarray datasets.
|
30176945 |
2018 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
Total protein extracts from Huh7-D12 cells and of the corresponding non transfected human liver carcinoma cell line, Huh7, were separated by 2-DE.
|
19136081 |
2009 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
GeneticVariation |
BEFREE |
In vivo, GPC3-ENG MSCs ± costimulatory molecules had antitumor activity in the HUH7 HCC xenograft model, resulting in a survival advantage.
|
28856237 |
2017 |
|
MIR7-3HG
|
Liver carcinoma
|
0.100 |
Biomarker |
BEFREE |
These results suggest that Celastrol and its combination with PHA present the therapeutic potential on c-Met-deficient hepatocellular carcinoma, and deserve further preclinical and clinical studies.
|
23649759 |
2013 |